'Study 003 6 mwd' presentation slideshows

FDA Review of Clinical Data Laronidase for the treatment of Mucopolysaccharidosis I

FDA Review of Clinical Data Laronidase for the treatment of Mucopolysaccharidosis I BioMarin Pharmaceuticals, Inc. FDA/Center for Biologics Evaluation and Research. Introduction. BioMarin proposes the use of laronidase for the treatment of patients with MPS I

673 views • 52 slides